These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 934438)

  • 1. Failure of dexamphetamine to antagonise a cholinomimetic-induced hyperactivity.
    Wray SR
    Neuropharmacology; 1976 May; 15(5):269-71. PubMed ID: 934438
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential attenuation by atropine and d-amphetamine on hyperactivity: possible clinical implications.
    Egbe PC; Wray SR
    Psychopharmacology (Berl); 1977 Aug; 54(1):25-30. PubMed ID: 410057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of dopaminergic neurotransmission in locomotor stimulation by dexamphetamine and ethanol.
    Strömbom UH; Liedman B
    Psychopharmacology (Berl); 1982; 78(3):271-6. PubMed ID: 6296902
    [No Abstract]   [Full Text] [Related]  

  • 4. Motility response to morphine and amphetamine during chronic inhibition of tyrosine hydroxylase or dopamine beta-hydroxylase.
    Khalsa JH; Davis WM
    J Pharmacol Exp Ther; 1977 Jul; 202(1):182-91. PubMed ID: 17725
    [No Abstract]   [Full Text] [Related]  

  • 5. Potentiation of a non-narcotic analgesic, dipyrone, by cholinomimetic drugs.
    Kamat UG; Pradhan RJ; Sheth UK
    Psychopharmacologia; 1972; 23(2):180-6. PubMed ID: 5022608
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of D-amphetamine and physostigmine upon acquisition and retrieval in a single trial learning task.
    Bohdanecky Z; Jarvik ME
    Arch Int Pharmacodyn Ther; 1967 Nov; 170(1):58-65. PubMed ID: 6056593
    [No Abstract]   [Full Text] [Related]  

  • 7. Decreases in behavioral and striatal neuronal responses to dexamphetamine with aging.
    Warenycia MW; McKenzie GM
    Pharmacol Biochem Behav; 1989 Jun; 33(2):489-91. PubMed ID: 2813486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of catecholamines on dexamphetamine-induced changes in locomotor activity.
    Handley SL; Thomas KV
    Psychopharmacology (Berl); 1978 Jul; 58(3):283-8. PubMed ID: 98799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological evidence for the involvement of GABA-ergic system in the locomotor stimulation produced in mice by 1,3-dimethyl-5-aminoadamantane (D-145).
    Menon MK; Clark WG
    Neuropharmacology; 1978 Dec; 17(12):1049-52. PubMed ID: 745691
    [No Abstract]   [Full Text] [Related]  

  • 10. A study of the role of catecholamines in the response to various central stimulants.
    Sayers AC; Handley SL
    Eur J Pharmacol; 1973 Jul; 23(1):47-55. PubMed ID: 4147437
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of humoral modulators of morphine-induced increase in locomotor activity of mice.
    Oka T; Hosoya E
    Jpn J Pharmacol; 1976 Oct; 26(5):615-9. PubMed ID: 137340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The involvement of the catecholaminergic system in physostigmine-induced hyperactivity in rats.
    Egbe PC
    Arzneimittelforschung; 1982; 32(1):27-9. PubMed ID: 6460507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial suppression of the locomotor stimulant response to dexamphetamine in rats exposed to a novel environment.
    Miller AA; Sethna DM; Young PA
    Br J Pharmacol; 1970 May; 39(1):230P-232P. PubMed ID: 5420122
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuroleptic antagonism of the motor inhibitory effects of apomorphine within the nucleus accumbens: drug interaction at presynaptic receptors?
    Costall B; Fortune DH; Hui SC; Naylor RJ
    Eur J Pharmacol; 1980 May; 63(4):347-58. PubMed ID: 6104603
    [No Abstract]   [Full Text] [Related]  

  • 15. Modulation of dexamphetamine-induced compulsive gnawing--including the possible involvement of presynaptic alpha-adrenoreceptors.
    Thomas KV; Handley SL
    Psychopharmacology (Berl); 1978 Jan; 56(1):61-7. PubMed ID: 203967
    [No Abstract]   [Full Text] [Related]  

  • 16. Magnesium valproate attenuates hyperactivity induced by dexamphetamine-chlordiazepoxide mixture in rodents.
    Cao BJ; Peng NA
    Eur J Pharmacol; 1993 Jun; 237(2-3):177-81. PubMed ID: 8103460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shock-induced locomotor excitation following acute and chronic amphetamine treatment.
    Kokkinidis L; Irwin J; Anisman H
    Neuropharmacology; 1979 Jan; 18(1):13-22. PubMed ID: 33347
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison of the locomotor stimulant properties of amantadine and l- and d-amphetamine in mice.
    Thornburg JE; Moore KE
    Neuropharmacology; 1972 Sep; 11(5):675-82. PubMed ID: 4151250
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of adrenergic blockade on locomotor stimulation induced by a low dose of physostigmine.
    Egbe PC
    Arzneimittelforschung; 1982; 32(12):1540-1. PubMed ID: 6891593
    [No Abstract]   [Full Text] [Related]  

  • 20. Ventricular infusion of norepinephrine and amphetamine: direct versus indirect action.
    Segal DS; McAllister C; Geyer MA
    Pharmacol Biochem Behav; 1974; 2(1):79-86. PubMed ID: 4857225
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.